Cancer vaccines: past, present, and future

Mahfoozur Rahman; Kainat Alam; Sarwar Beg; Deeksha Chauhan; Vikas Kumar; Abdul Hafeez; Ankit Sahoo; Waleed H. Almalki; Mohammad Javed Ansari

doi:10.1016/B978-0-12-823686-4.00007-0

Cancer vaccines: past, present, and future

Mahfoozur Rahman
, Kainat Alam
, Sarwar Beg
, Deeksha Chauhan
, Vikas Kumar
, Abdul Hafeez
, Ankit Sahoo
, Waleed H. Almalki
, Mohammad Javed Ansari

Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

3 Scopus citations

Abstract

The worldwide cancer burden has increased, driving the search for novel treatment options. Cancer vaccines were first developed about three decades ago, with gene therapy intervention improvements for the treatment of various malignancies. Limited targeting ability due to the tumors is a common issue with cancer vaccinations. Targeting tumor cells using nanocarriers has being explored as a new technology for gene therapy. This technology explores how nanotherapeutic systems have advanced in order to make more effective genetic vaccines for cancer therapy.

Original language	English
Title of host publication	Nanotherapeutics in Cancer Vaccination and Challenges
Publisher	Elsevier
Pages	1-12
Number of pages	12
ISBN (Electronic)	9780128236864
ISBN (Print)	9780128236871
DOIs	https://doi.org/10.1016/B978-0-12-823686-4.00007-0
State	Published - 1 Jan 2022
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Cancers
Nanomedicines
Nanoparticles
Tumour targeting
Vaccines

Access to Document

10.1016/B978-0-12-823686-4.00007-0

Cite this

@inbook{371b2bdcffb441a792ecc287e0c431c2,

title = "Cancer vaccines: past, present, and future",

abstract = "The worldwide cancer burden has increased, driving the search for novel treatment options. Cancer vaccines were first developed about three decades ago, with gene therapy intervention improvements for the treatment of various malignancies. Limited targeting ability due to the tumors is a common issue with cancer vaccinations. Targeting tumor cells using nanocarriers has being explored as a new technology for gene therapy. This technology explores how nanotherapeutic systems have advanced in order to make more effective genetic vaccines for cancer therapy.",

keywords = "Cancers, Nanomedicines, Nanoparticles, Tumour targeting, Vaccines",

author = "Mahfoozur Rahman and Kainat Alam and Sarwar Beg and Deeksha Chauhan and Vikas Kumar and Abdul Hafeez and Ankit Sahoo and Almalki, \{Waleed H.\} and Ansari, \{Mohammad Javed\}",

year = "2022",

month = jan,

day = "1",

doi = "10.1016/B978-0-12-823686-4.00007-0",

language = "English",

isbn = "9780128236871",

pages = "1--12",

booktitle = "Nanotherapeutics in Cancer Vaccination and Challenges",

publisher = "Elsevier",

address = "Netherlands",

}

TY - CHAP

T1 - Cancer vaccines

T2 - past, present, and future

AU - Rahman, Mahfoozur

AU - Alam, Kainat

AU - Beg, Sarwar

AU - Chauhan, Deeksha

AU - Kumar, Vikas

AU - Hafeez, Abdul

AU - Sahoo, Ankit

AU - Almalki, Waleed H.

AU - Ansari, Mohammad Javed

PY - 2022/1/1

Y1 - 2022/1/1

N2 - The worldwide cancer burden has increased, driving the search for novel treatment options. Cancer vaccines were first developed about three decades ago, with gene therapy intervention improvements for the treatment of various malignancies. Limited targeting ability due to the tumors is a common issue with cancer vaccinations. Targeting tumor cells using nanocarriers has being explored as a new technology for gene therapy. This technology explores how nanotherapeutic systems have advanced in order to make more effective genetic vaccines for cancer therapy.

AB - The worldwide cancer burden has increased, driving the search for novel treatment options. Cancer vaccines were first developed about three decades ago, with gene therapy intervention improvements for the treatment of various malignancies. Limited targeting ability due to the tumors is a common issue with cancer vaccinations. Targeting tumor cells using nanocarriers has being explored as a new technology for gene therapy. This technology explores how nanotherapeutic systems have advanced in order to make more effective genetic vaccines for cancer therapy.

KW - Cancers

KW - Nanomedicines

KW - Nanoparticles

KW - Tumour targeting

KW - Vaccines

UR - https://www.scopus.com/pages/publications/85141066657

U2 - 10.1016/B978-0-12-823686-4.00007-0

DO - 10.1016/B978-0-12-823686-4.00007-0

M3 - Chapter

AN - SCOPUS:85141066657

SN - 9780128236871

SP - 1

EP - 12

BT - Nanotherapeutics in Cancer Vaccination and Challenges

PB - Elsevier

ER -

Cancer vaccines: past, present, and future

Abstract

UN SDGs

Keywords

Access to Document

Other files and links

Fingerprint

Cite this